Escient Pharmaceuticals
Escient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018.
4
Funding Rounds
$312.5m
Money raised
Funding series
Funding Series Analysis
The company Escient Pharmaceuticals has raised a total of $120m in funding over 4 rounds.
Key Insights:
- Escient Pharmaceuticals - Series C round, November 2022: $120m
- Escient Pharmaceuticals Inc funding round, August 2020: $75m
- Escient Pharmaceuticals Series B round September 2020: $77.5m
- Escient Pharmaceuticals funding round, May 2018: $40m
Escient Pharmaceuticals - Series C round, November 2022
$120m
Escient Pharmaceuticals Inc funding round, August 2020
$75m
Escient Pharmaceuticals Series B round September 2020
$77.5m
Escient Pharmaceuticals funding round, May 2018
$40m
Industries
Escient Pharmaceuticals is active in the following industries: